Neural stem cell transplantation and CNS diseases

CNS and Neurological Disorders - Drug Targets

Volumn 15, Issue 8, 2016, Pages 881-886

  Gonzalez, Rodolfo ^b   Hamblin, Milton H ^a   Lee, Jean Pyo ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Chemokine receptor; Chemokines; Embryonic stem cells; Induced pluripotent stem cells; Inflammation; Lysosomal storage diseases; Neural stem cells; Neurodegenerative diseases; Stem cell migration; Stem cell therapy; Transplantation

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; HUMAN; INFLAMMATION; NERVE DEGENERATION; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASES; NEURAL STEM CELL; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84989245524     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527315666160815164247     Document Type: Review

References (26)

1. Temple, S. The development of neural stem cells. Nature 2001; 414: 112-7.
2. Reubinoff BE, Itsykson P, Turetsky T, et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001; 19: 1134-40.
3. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001; 19: 1129-33.
4. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275-80.
5. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
6. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-86.
7. Soldner F, Laganiere J, Cheng AW, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011; 146: 318-31.
8. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218-21.
9. Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221-5.
10. Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277-80.
11. Israel MA, Yuan SH, Bardy C, et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells. Nature 2012; 482: 216-20.
12. Wichterle H, Przedborski S. What can pluripotent stem cells teach us about neurodegenerative diseases? Nat Neurosci 2010; 13: 800-4.
13. Jeyakumar M, Lee JP, Sibson NR, et al. Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease. Stem Cells 2009; 27(9): 2362-70.
14. Politi LS, Bacigaluppi M, Brambilla E, et al. Magnetic-resonancebased tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 2007; 25: 2583-92.
15. Lee JP, Tsai DJ, In Park K, Harvey AR, Snyder EY. The dynamics of long-term transgene expression in engrafted neural stem cells. J Comp Neurol 2009; 515: 83-92.
16. Lecanu L. Sex, the underestimated potential determining factor in brain tissue repair strategy. Stem Cells Dev 2011; 20: 2031-5.
17. Lee JP, Jeyakumar M, Gonzalez R, et al. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med 2007; 13: 439-47.
18. Snyder EY, Flax JD. Transplantation of neural progenitor and stem-like cells as a strategy for gene therapy and repair of neurodegenerative diseases. Ment Retard Dev Disabil Res Rev 1995; 1: 27-38.
19. Yandava BD, Billinghurst LL, Snyder EY. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 1999; 96: 7029-34.
20. Taylor RM, Lee JP, Palacino JJ, et al. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy. J Neurochem 2006; 97: 1585-99.
21. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metabol 1999; 19: 819-34.
22. Yin KJ, Deng Z, Hamblin M, Zhang J, Chen YE. Vascular PPARdelta protects against stroke-induced brain injury. Arterioscler Thromb Vascul Biol 2011; 31: 574-81.
23. Imitola J, Comabella M, Chandraker AK, et al. Neural stem/ progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. Am J Pathol 2004; 164: 1615-25.
24. Ourednik V, Ourednik J, Flax JD, et al. Segregation of human neural stem cells in the developing primate forebrain. Science 2001; 293: 1820-4.
25. Redmond DE Jr, Bjugstad KB, Teng YD, et al. Behavioral improvement in a primate Parkinson’s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 2007; 104: 12175-80.
26. Teng YD, Benn SC, Kalkanis SN, et al. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med 2012; 4: 165ra164.